Biotechnology
Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial.
SHANGHAI, Oct. 31, 2026 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ( "Zhimeng Biopharma")announced today that its independently developed next-generation potassium channel opener, CB03-154, intended for the treatment of amyotrophic lateral sclerosis (ALS), has successfullycompleted patient ...
2026-10-31 13:00
266
Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
BOSTON, Oct. 30, 2026 /PRNewswire/ -- Dr. Yang Liu, Director of Medicinal Chemistry at Revolution Medicines, Inc., and Dr. Kristof Pota, Senior Scientist, visited Medicilon's Nanhui R&D Center. Dr. Maosheng Duan, President of Medicilon's Drug Discovery and Pharmaceutical Research Divisions, Dr. J...
2026-10-31 00:00
18
aphranel® Hosts European Physicians in China for Clinical Exchange
Week-Long Programme Under The Norns' Weave Examines Chinese Clinical Practice and Its Potential Applications in Europe SHANGHAI, Oct. 30, 2026 /PRNewswire/ -- aphranel®, the regenerative aesthetics brand of MOYOM Biotech, has launched a clinical exchange programme bringing European physicians to...
2026-10-30 17:00
2580
Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation
Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%), including patients previously treated with enfortumab vedotin and pembrolizumab Early antitumor activity also observed in squamous NSCLC, SCLC and prostate cancer SHANGHAI and HANGZHOU, China, Oct. 29, 2026 ...
2026-10-30 09:00
3584
Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing next-generation, long-acting precisionbispecific antibodies for immunology and inflammation, today announced the pricing of ...
2026-10-30 08:15
3790
Asymchem Completes its First USFDA Pre-Approval Inspection (PAI) of the Tianjin 4 TIDES Manufacturing Site
TIANJIN, China, Oct. 29, 2026 /PRNewswire/ -- Asymchem successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection (PAI) of Asymchem Life Science (Tianjin) Co., Ltd.'s TIDES development and manufacturing facility ("TJ4"), which took place between June 29th t...
2026-10-29 21:30
4472
OncoC4 Announces Oral Presentation of a Late-Breaking Abstract on Cesalatamig at the 41st Annual Meeting of SITC
— Global Phase 1/2 Study Data in PD-(L)1–Resistant/Refractory NSCLC to Be Presented on November 7, 2026 — — Clinical Oral Abstract Session 2 Begins at 1:45 PM MST — ROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- OncoC4 Inc., a late clinical-stage biopharmaceutical company developing novel medicin...
2026-10-29 21:30
5237
Yuyu Pharma Explores Animal Health as a New Pathway for Human Drug Innovation
SEOUL, South Korea, Oct. 29, 2026 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) CEO Robert Wonsang Yu shared the company's vision for connecting human and animal health at BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), highlighting how pharmaceutical research and development can create new opportunities ac...
2026-10-29 21:00
8
Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference
SYDNEY, Oct. 29, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-10-29 19:00
9
United Imaging Healthcare Reports 19.43% Revenue Growth in First Nine Months of 2026, with Cumulative R&D Investment Exceeding RMB 10 Billion Since 2022
SHANGHAI, Oct. 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH), a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, reported revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year. Sustained investment in...
2026-10-29 15:32
3615
SGH's AI tool wins international award for improving antibiotic use
SINGAPORE, Oct. 29, 2026 /PRNewswire/ -- Singapore General Hospital (SGH) has won the Silver Award in the Dr Prathap C Reddy Excellence Award for Clinical Quality and Patient Safety at the International Hospital Federation (IHF) Awards 2026, for its Augmented Intelligence in Infectious Diseases (...
2026-10-29 14:00
2933
Median PFS Approaches 14 Months! 3SBio's PD-1/VEGF Bispecific Antibody Posts Impressive Data at ESMO 2026
SHANGHAI, Oct. 28, 2026 /PRNewswire/ -- At the 2026 European Society for Medical Oncology (ESMO) Congress, 3SBio presented long-term follow-up results from a Chinese Phase II clinical study of SSGJ-707 combined with chemotherapy as a first-line treatment for advanced non-small cell lung cancer (N...
2026-10-28 20:56
3128
CELSET Launches SOLTOX, a Korean Botulinum Toxin Type A Brand, for International Markets
SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ -- CELSET INC., a Korean
biotechnology company specializing in medical aesthetics, has launched SOLTOX,
its botulinum toxin type A brand, introducing a Korean botulinum toxin brand to
the international medical aesthetics industry.
2026-10-28 16:00
2591
Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment
SHANGHAI, Oct. 28, 2026 /PRNewswire/ -- Jiahui International Hospital launched Jiahui International Cell Therapy Center, building on landmark CAR-T cases and multidisciplinary expertise to serve patients from China and abroad. The center was unveiled at the inaugural Jiahui International Cell The...
2026-10-28 14:41
The Jumbophage Cocktail_Fighting Superbugs and Shrimp Disease
BANGKOK, Oct. 28, 2026 /PRNewswire/ -- What if a weapon against some of the world's most stubborn bacteria were hiding in the soil beneath our feet? Could these microscopic hunters help us confront antibiotic-resistant "superbugs" and bacterial diseases devastating shrimp? The answer may lie in u...
2026-10-28 14:24
6
From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment
Record 64 Research Presentations Highlight Hengrui's Oncology R&D Strength and Growing International Reach MADRID and SHANGHAI, Oct. 27, 2026 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded in Madrid. As a leading innovator in China's pharmaceuti...
2026-10-28 11:32
3611
Fosun Health Makes Historic Debut at Canton Fair, Foshan Fosun Chancheng Hospital Showcases International Healthcare Services
GUANGZHOU, China, Oct. 28, 2026 /PRNewswire/ -- Fosun Health has become the first cross-border international healthcare group to exhibit at the Canton Fair in its 70-year history, debuting at the event's inaugural International Healthcare Zone alongside four Greater Bay Area (GBA) hospitals, incl...
2026-10-28 08:00
12
Natural Field to Showcase Liposomal Delivery and Formulation Solutions at SupplySide Global 2026
LAS VEGAS, Oct. 27, 2026 /PRNewswire/ -- As nutrition brands explore increasingly complex product formulations, the relationship between functional ingredients, delivery technologies, and application-specific formulation design is becoming an important consideration in product development. Natura...
2026-10-27 23:09
2432
Fios Genomics bioinformatics team and services move to Excelra
Edinburgh-based team joins Excelra's scientific consulting group, strengthening
its omics analytics expertise and presence in the UK and Europe
EDINBURGH, Scotland and HYDERABAD, India, Oct. 27, 2026 /PRNewswire/ --
Excelra
2026-10-27 23:00
2418
Registrational Phase III CLARIFY trial: Target number of participants achieved
SYDNEY, Oct. 27, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the registration...
2026-10-27 21:02
2822
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 310 media titles]
2026-10-27 13:40
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00
Pepperstone and Aston Martin Aramco extend and expand partnership with Fernando Alonso appointed Global Ambassador from 2027.
[Picked up by 276 media titles]
2026-10-29 13:01
Most Read
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
45457
The Future of AI 3D Character Workflows: Reallusion CC 5.2 Turns Meshes into Living Characters
2026-10-29 20:03
20938
ROKAE delivers its 10,000th humanoid force-controlled arm
2026-10-27 00:00
18441
